Issued Patents All Time
Showing 151–175 of 180 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9150648 | Anti-ASIC1 antibodies and uses thereof | Min Gao, Marc R. Morra, Nicole Alessandri-Haber, Michael L. LaCroix-Fralish | 2015-10-06 |
| 9150662 | Hybrid light chain mice | Sean Stevens, Cagan Gurer, Andrew J. Murphy, Karolina A. Meagher | 2015-10-06 |
| 9113616 | Genetically modified mice having humanized TCR variable genes | Andrew J. Murphy, John McWhirter, Naxin Tu, Vera Voronina, Cagan Gurer +2 more | 2015-08-25 |
| 9089599 | Low affinity FCGR deficient mice | Naxin Tu, Cagan Gurer, Sean Stevens, Andrew J. Murphy | 2015-07-28 |
| 9066502 | Hybrid light chain mice | Sean Stevens, Cagan Gurer, Andrew J. Murphy, Karolina A. Meagher | 2015-06-30 |
| 9056130 | Humanized Fc gamma R mice | Naxin Tu, Cagan Gurer, Sean Stevens, Andrew J. Murphy | 2015-06-16 |
| 9043996 | Genetically modified major histocompatibility complex animals | Andrew J. Murphy, Naxin Tu, Cagan Gurer, Vera Voronina, Sean Stevens | 2015-06-02 |
| 9035128 | Hybrid light chain mice | Sean Stevens, Cagan Gurer, Andrew J. Murphy, Karolina A. Hosiawa | 2015-05-19 |
| 9028819 | Methods of alleviating itch by administering human antibodies to human protease-activated receptor 2 | Andrew J. Murphy, Nicholas J. Papadopoulos, Marc R. Morra, Robert Salzler, Michael L. LaCroix-Fralish | 2015-05-12 |
| 9029628 | Human lambda light chain mice | Sean Stevens, Cagan Gurer, Andrew J. Murphy, Karolina A. Meagher | 2015-05-12 |
| 9012717 | Human lambda light chain mice | Sean Stevens, Cagan Gurer, Andrew J. Murphy, Karolina A. Hosiawa | 2015-04-21 |
| 9006511 | Human lambda light chain mice | Sean Stevens, Cagan Gurer, Andrew J. Murphy, Karolina A. Meagher | 2015-04-14 |
| 8968736 | Human antibodies to GFRα3 and methods of use thereof | Susan D. Croll, Andrew J. Murphy | 2015-03-03 |
| 8883496 | Humanized FcgR mice | Naxin Tu, Cagan Gurer, Li-Hsien Wang, Sean Stevens, Andrew J. Murphy | 2014-11-11 |
| 8871996 | Mice expressing human voltage-gated sodium channels | Andrew J. Murphy, Michael L. LaCroix-Fralish, Nicole M. Alessandri Haber | 2014-10-28 |
| 8847005 | Genetically modified major histocompatibility complex mice | Andrew J. Murphy, Naxin Tu, Cagan Gurer, Vera Voronina, Sean Stevens | 2014-09-30 |
| 8791323 | Hybrid antibodies comprising human variable regions and mouse constant regions produced in a genetically modified mouse | Andrew J. Murphy, George D. Yancopoulos, Margaret Karow, Sean Stevens, Aris N. Economides +1 more | 2014-07-29 |
| 8754287 | Mice that make heavy chain antibodies | Sean Stevens, Andrew J. Murphy | 2014-06-17 |
| 8697940 | ADAM6 mice | Sean Stevens, Andrew J. Murphy | 2014-04-15 |
| 8658154 | Humanized FcγR mice | Naxin Tu, Cagan Gurer, Sean Stevens, Andrew J. Murphy | 2014-02-25 |
| 8658853 | Low affinity FcγR deficient mice | Naxin Tu, Cagan Gurer, Sean Stevens, Andrew J. Murphy | 2014-02-25 |
| 8642835 | ADAM6 mice | Sean Stevens, Andrew J. Murphy | 2014-02-04 |
| 8637031 | Method of treating osteoarthritis with an antibody to NGF | Richard Torres, Marc R. Morra, Joel H. Martin, Joel C. Reinhardt, Paul Tiseo | 2014-01-28 |
| 8613927 | High affinity human antibodies to human nerve growth factor | Richard Torres, Marc R. Morra, Joel H. Martin, Joel C. Reinhardt | 2013-12-24 |
| 8486647 | Neuropeptide release assay for sodium channels | Nicole M. Alessandri Haber, Michael L. LaCroix-Fralish, Andrew J. Murphy | 2013-07-16 |